340B Care for Patients With Low Incomes
A Sept. 24 story in the New York Times discussing the 340B drug pricing program does not reflect the critical role 340B and 340B hospitals play in treating our nation’s most vulnerable patients – those living with low incomes and those who live in often underserved rural communities. Read our statement on the story.
A large and growing body of research demonstrates that 340B has enabled hospitals and health systems throughout the U.S. to provide crucial care to patients with low incomes, especially Medicaid and low-income Medicare patients. We have compiled that information into a 340B Hospitals Research Overview that cites relevant data from 340B health studies and independent studies to show how 340B is meeting Congress' intent to help patients in need. The overview includes the newest 340B Health report: 340B DSH Hospitals Serve Higher Share of Patients With Low Incomes.
